Conversion therapy has become a hot topic among specialists in gastrointestinal cancers, said Pamela Kunz, MD, of the Yale ...

The generic drugmaker was the top loser on the Nifty Pharma index and the benchmark Nifty 50 index. "The drop in shares comes ...

Unusual total active option classes on open include: B2Gold ( BTG ), Verizon ( VZ ), Zscaler ( ZS ), American Express ( AXP ), Mastercard ( MA ), KE Holdings ( BEKE ), Novo Nordisk ( NVO ), Microchip ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The unsuccessful Phase III results are the latest to suggest that the blockbuster cancer drug is finally bumping up against ...

Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...

Clinicians may one day be able to treat immune checkpoint inhibitor-related myocarditis without disrupting cancer therapy, findings from a cellular investigation showed.Individuals who die of immune ...

The Board also approved a Miss. State career center funded through the U.S. Department of Education Rehabilitation Services ...

That's significant because the GI tract is the most common site of bleeding with DOACs, and this type of bleeding is the only one for which DOACs do not have a better risk profile ...

Ozanimod▼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...